What top creators are saying about Axsome Therapeutics, Inc.(AXSM)
A biopharmaceutical company that acquired the rights to Sunosi (solriamfetol).
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Axsome Therapeutics, Inc. in the last 30 days yet.
Top creators covering Axsome Therapeutics, Inc. (AXSM)
The 1 sources with the most insights about Axsome Therapeutics, Inc. on Kazuha.
Latest insights about Axsome Therapeutics, Inc. (AXSM)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Monday, March 9, 2026
Sunosi is showing promise for ADHD with a gentler effect profile than traditional stimulants like Adderall.
Monday, March 9, 2026
Sunosi is showing promise for ADHD with a gentler effect profile than traditional stimulants like Adderall.
Discussed alongside Axsome Therapeutics, Inc. (AXSM)
Other assets that creators frequently mention in the same content as Axsome Therapeutics, Inc..
Frequently asked
Which podcasters and creators cover Axsome Therapeutics, Inc. (AXSM) the most?
The most active sources covering Axsome Therapeutics, Inc. (AXSM) on Kazuha are Andreessen Horowitz. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Axsome Therapeutics, Inc. (AXSM) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Axsome Therapeutics, Inc. (AXSM) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Axsome Therapeutics, Inc. (AXSM)?
Creators covering Axsome Therapeutics, Inc. (AXSM) most frequently also discuss PRIVATE, LLY, PRIVATE, PRIVATE, PRIVATE. See the "Discussed alongside" section above for full asset pages.